Compound ID | 2082
Class: Antibacterial sulfonamide (sulfa drug)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Antiinflammatory action |
Description: | Synthetic sufanilamide derivative. Prodrug with active metabolites 5-aminosalicylic acid and sulfapyridine. Oral use as antiinflammatory drug for ulcerative colitis, Crohn's disease and rheumatoid arthritis. |
Year first mentioned: | 1959 |
Development status: | Approved, off-patent |
Chemical structure(s): | |
Canonical SMILES: | C1=CC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC=C(C(=C3)C(=O)O)O |
Isomeric SMILES: | C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O |
InChI: | InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25) |
InChI Key: | NCEXYHBECQHGNR-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5339 |
External links: | |
Guide to Pharmacology: | sulfasalazine |
Main Source: | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/007073s124lbl.pdf |